600211 西藏药业
2023/122022/122021/122020/122019/12

盈利能力分析
净资产收益率 ROE (%)25.20013.1108.02616.68013.320
总资产报酬率 ROA (%)18.4399.3606.19414.64011.787
投入资产回报率 ROIC (%)21.71111.0287.23016.62513.316

边际利润分析
销售毛利率 (%)95.05294.25889.56285.80183.548
营业利润率 (%)28.68518.18912.00834.38327.963
息税前利润/营业总收入 (%)27.58118.30712.23233.26627.158
净利润/营业总收入 (%)25.85114.6919.96130.63625.268

收益指标分析
经营活动净收益/利润总额(%)119.799160.019222.55889.722100.104
价值变动净收益/利润总额(%)-18.937-1.54157.4740.202-0.835
营业外收支净额/利润总额(%)-0.100-0.272-0.765-0.3830.409

偿债能力分析
流动比率 (X)2.8732.6431.9664.0564.328
速动比率 (X)2.7792.5451.8433.8444.087
资产负债率 (%)26.45826.07230.4430.12111.580
带息债务/全部投入资本 (%)12.56513.21015.9850.128-0.395
股东权益/带息债务 (%)689.815647.811516.18077,614.078-25,314.164
股东权益/负债合计 (%)275.561281.766227.218723.810760.533
利息保障倍数 (X)-25.643108.98638.756-33.728-29.529

营运能力分析
应收账款周转天数 (天)63.03864.69167.69283.92298.314
存货周转天数 (天)245.342291.134167.867134.294119.229